ALA 3.57% 13.5¢ arovella therapeutics limited

New Baker interview, page-54

  1. 3,664 Posts.
    lightbulb Created with Sketch. 657
    "Suda needs to be concentrating on is Teva deal and seeing why it's over 12 months late, the data used was all based on the FDA application so why no approval, the Australia Zolpimist application is also based on the same data, this doesnt look good "


    its fine...

    Teva deal is Teva's IP you wont hear anything about it til Teva say so.

    Australian zolpi MAA is an application between Suda and the TGA we will get an outcome inside the start of April and ann

    Last edited by Beale: 27/01/20
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
13.5¢
Change
-0.005(3.57%)
Mkt cap ! $141.9M
Open High Low Value Volume
14.0¢ 14.5¢ 13.5¢ $47.47K 339.8K

Buyers (Bids)

No. Vol. Price($)
9 397943 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.0¢ 66403 3
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.